Massive study pits top diabetes drugs against each other
NCT ID NCT05220917
Summary
This large observational study aims to compare the real-world effectiveness and safety of four common second-line type 2 diabetes medications. It will look at how well they prevent heart attacks, strokes, heart failure, and kidney problems in over 780,000 patients. The goal is to help doctors and patients choose the best medication by directly comparing their risks and benefits for heart and kidney health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02120, United States
Conditions
Explore the condition pages connected to this study.